Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1834 1
1884 1
1899 1
1905 1
1941 1
1946 1
1947 1
1948 1
1949 4
1950 1
1951 2
1952 2
1953 3
1954 1
1955 1
1956 1
1957 2
1958 4
1959 6
1960 3
1961 5
1962 5
1963 7
1964 4
1965 12
1966 3
1967 5
1968 3
1969 4
1970 5
1971 4
1972 6
1973 9
1974 18
1975 5
1976 11
1977 9
1978 10
1979 15
1980 12
1981 5
1982 12
1983 11
1984 16
1985 12
1986 13
1987 19
1988 18
1989 18
1990 21
1991 26
1992 23
1993 12
1994 21
1995 21
1996 17
1997 29
1998 29
1999 27
2000 25
2001 39
2002 34
2003 36
2004 30
2005 41
2006 30
2007 45
2008 30
2009 37
2010 41
2011 45
2012 60
2013 41
2014 69
2015 80
2016 108
2017 101
2018 116
2019 105
2020 123
2021 138
2022 121
2023 115
2024 111
2025 92
2026 47

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,199 results

Results by year

Filters applied: . Clear all
Page 1
Non-pharmacological interventions for persistent postural-perceptual dizziness (PPPD).
Webster KE, Kamo T, Smith L, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, Ray J, Van Vugt VA, Burton MJ. Webster KE, et al. Among authors: ray j. Cochrane Database Syst Rev. 2023 Mar 13;3(3):CD015333. doi: 10.1002/14651858.CD015333.pub2. Cochrane Database Syst Rev. 2023. PMID: 36912784 Free PMC article.
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial.
Wang ES, Issa GC, Erba HP, Altman JK, Montesinos P, DeBotton S, Walter RB, Pettit K, Savona MR, Shah MV, Kremyanskaya M, Baer MR, Foran JM, Schiller G, Adès L, Heiblig M, Berthon C, Peterlin P, Rodríguez-Arbolí E, Salamero O, Patnaik MM, Papayannidis C, Grembecka J, Cierpicki T, Clegg B, Ray J, Linhares BM, Nie K, Mitra A, Ahsan JM, Tabachri M, Soifer HS, Corum D, Leoni M, Dale S, Fathi AT. Wang ES, et al. Among authors: ray j. Lancet Oncol. 2024 Oct;25(10):1310-1324. doi: 10.1016/S1470-2045(24)00386-3. Lancet Oncol. 2024. PMID: 39362248 Clinical Trial.
Systemic pharmacological interventions for Ménière's disease.
Webster KE, Galbraith K, Harrington-Benton NA, Judd O, Kaski D, Maarsingh OR, MacKeith S, Ray J, Van Vugt VA, Burton MJ. Webster KE, et al. Among authors: ray j. Cochrane Database Syst Rev. 2023 Feb 23;2(2):CD015171. doi: 10.1002/14651858.CD015171.pub2. Cochrane Database Syst Rev. 2023. PMID: 36827524 Free PMC article.
Interventional treatments.
Kissoon NR, Ray JC, Hutton E. Kissoon NR, et al. Among authors: ray jc. Handb Clin Neurol. 2024;199:145-153. doi: 10.1016/B978-0-12-823357-3.00002-1. Handb Clin Neurol. 2024. PMID: 38307642 Review.
Genome-wide enhancer maps link risk variants to disease genes.
Nasser J, Bergman DT, Fulco CP, Guckelberger P, Doughty BR, Patwardhan TA, Jones TR, Nguyen TH, Ulirsch JC, Lekschas F, Mualim K, Natri HM, Weeks EM, Munson G, Kane M, Kang HY, Cui A, Ray JP, Eisenhaure TM, Collins RL, Dey K, Pfister H, Price AL, Epstein CB, Kundaje A, Xavier RJ, Daly MJ, Huang H, Finucane HK, Hacohen N, Lander ES, Engreitz JM. Nasser J, et al. Among authors: ray jp. Nature. 2021 May;593(7858):238-243. doi: 10.1038/s41586-021-03446-x. Epub 2021 Apr 7. Nature. 2021. PMID: 33828297 Free PMC article.
A haplotype-resolved view of human gene regulation.
Vollger MR, Swanson EG, Neph SJ, Ranchalis J, Munson KM, Ho CH, Cheng YHH, Sedeño-Cortés AE, Fondrie WE, Bohaczuk SC, Dippel MA, Mao Y, Parmalee NL, Mallory BJ, Harvey WT, Kwon Y, Garcia GH, Hoekzema K, Meyer JG, Cicek M, Eichler EE, Noble WS, Witten DM, Bennett JT, Ray JP, Stergachis AB. Vollger MR, et al. Among authors: ray jp. bioRxiv [Preprint]. 2025 Jun 2:2024.06.14.599122. doi: 10.1101/2024.06.14.599122. bioRxiv. 2025. PMID: 40501892 Free PMC article. Preprint.
SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors.
Wing S, Ray JG, Yau K, Jeyakumar N, Abdullah S, Luo B, Cherney DZI, Harel Z, Hundemer GL, Mavrakanas TA, Molnar AO, Odutayo A, Perl J, Young A, Charytan D, Weir M, Wald R. Wing S, et al. Among authors: ray jg. JAMA Intern Med. 2025 Jul 1;185(7):827-836. doi: 10.1001/jamainternmed.2025.0686. JAMA Intern Med. 2025. PMID: 40293730 Free PMC article.
2,199 results